Over the past year, the Rapid Enterprise Platform has been implemented at an unmatched scale and speed in hundreds of health systems nationwide, demonstrating its ability to optimize operations, enhance connectivity, and scale to meet the demands of enterprise-level care.
The Rapid Enterprise Platform now includes advanced third-party technologies for detecting vertebral compression fractures (VCFs), cervical spine (C-spine) fractures, and incidental pulmonary embolisms (iPEs). With several additional modules slated for release in the near future, RapidAI continues to deliver a unified, high-performance ecosystem that empowers care teams to make faster, more accurate decisions across an expanding spectrum of clinical challenges.
Ad Statistics
Times Displayed: 78539
Times Visited: 2794 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
"As a radiologist, having an enterprise AI platform that integrates best-in-class, clinically validated technologies is transformative,” said Jonathan Clemente, MD FACR, Chief, Department of Radiology at Carolinas Medical Center, Vice President of the Medical Staff and Neuroradiologist at Charlotte Radiology in Charlotte, NC. “With RapidAI, I can trust that third-party products are vetted with the same clinical rigor as their flagship solutions. This gives me confidence in the platform’s ability to help analyze complex cases with speed and accuracy while catching details that could be easily overlooked in the urgency of the Code Stroke workflow."
Attendees of the Radiological Society of North America (RSNA) annual meeting are invited to visit RapidAI’s booth #5555 and its RSNA resource page to learn more about these advancements and their potential to enhance radiology workflows and patient care.
About RapidAI
RapidAI is the world leader in AI-driven medical imaging analysis and coordinated care. With the industry’s most validated clinical AI platform, we empower care teams to rapidly, precisely, and confidently manage life-threatening conditions. Trusted by thousands of hospitals in 100+ countries, RapidAI delivers the deepest level of clinical decision support on the market to help accelerate the time to treatment and enhance patient outcomes. We go beyond the algorithm to drive care team collaboration and efficiencies that expand access to life-saving interventions. At RapidAI, we establish new standards for care teams and the patients they treat.
Back to HCB News
